2025-04-01 04:56:21
Latest Post
Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks
ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited
AGI Greenpac Ltd approves ~ Rs. 700 crore capex
NHPC Ltd updates on 300 MW Bikaner Solar Power Project
Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd
Stock Report
Neuland Laboratories reports lower consolidated PAT of Rs. 12.93 crores in Q3 FY22
Posted On : 2022-02-01 14:47:37( TIMEZONE : IST )
Neuland Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 238.3699 crores during the period ended December 31, 2021 as compared to Rs. 258.1341 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 12.9356 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 20.3711 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 10.08 for the period ended December 31, 2021 as compared to Rs. 15.88 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 238.3699 crs | ₹258.1341 crs |  -7.66% |
| Net Profit | ₹12.9356 crs | ₹20.3711 crs | -36.50% |
| EPS | ₹10.08 | ₹15.88 | -36.52% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 238.3699 crores during the period ended December 31, 2021 as compared to Rs.245.5871 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.12.9356 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.26.7352 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.10.08 for the period ended December 31, 2021 as compared to Rs.20.84 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 238.3699 crs | ₹245.5871 crs | -2.94% |
| Net Profit | ₹12.9356 crs | ₹26.7352 crs | -51.62% |
| EPS | ₹10.08 | ₹20.84 | -51.63% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.699.4466 crores during the 9 Months period ended December 31, 2021 as compared to Rs.693.7070 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.42.0413 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.63.3381 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.32.77 for the 9 Months period ended December 31, 2021 as compared to Rs.49.37 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹699.4466 crs | ₹693.7070 crs |  0.83% |
| Net Profit | ₹42.0413 crs | ₹63.3381 crs | -33.62% |
| EPS | ₹32.77 | ₹49.37 | -33.62% |
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 1475.85 as compared to the previous close of Rs. 1474.45. The total number of shares traded during the day was 1492 in over 253 trades.
The stock hit an intraday high of Rs. 1508.45 and intraday low of 1462.80. The net turnover during the day was Rs. 2196337.00.
